CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
61.29
-0.59 (-0.95%)
At close: Mar 9, 2026, 4:00 PM EDT
61.29
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT

CG Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-161-88.04-48.61-35.44-12.84
Depreciation & Amortization
1.450.030.020.020.01
Other Amortization
--00.010.01
Loss (Gain) From Sale of Investments
-1.01-4.99-2.88--
Stock-Based Compensation
26.6811.41.530.681.11
Other Operating Activities
-0.73-0.020.820.50.02
Change in Accounts Receivable
-0.32----
Change in Inventory
-0.44----
Change in Accounts Payable
-1.643.282.01-0.020.58
Change in Other Net Operating Assets
4.68-0.371.434.46-2.55
Operating Cash Flow
-132.35-78.71-45.68-29.8-13.65
Capital Expenditures
-0.13-0.23--0.01-0.1
Cash Acquisitions
-21.97----
Investment in Securities
-223.72-300.53-121.2-55.34-
Investing Cash Flow
-245.82-300.76-121.2-55.35-0.1
Long-Term Debt Issued
----15.2
Long-Term Debt Repaid
--0.37-16.29--
Net Debt Issued (Repaid)
--0.37-16.29-15.2
Issuance of Common Stock
153.91632.072.080.170.25
Other Financing Activities
-0.32-3.42-3.42-0.47-
Financing Cash Flow
153.59628.2887119.6915.45
Net Cash Flow
-224.58248.8-79.8834.541.7
Free Cash Flow
-132.48-78.95-45.68-29.82-13.75
Free Cash Flow Margin
-3279.21%-6931.26%-22391.67%-15611.52%-132.76%
Free Cash Flow Per Share
-1.71-1.26-10.55-7.97-3.77
Cash Interest Paid
0.1-0.381.090.31
Cash Income Tax Paid
0.02----
Levered Free Cash Flow
-87.62-59.08-28.07-16.95-
Unlevered Free Cash Flow
-87.62-59.08-28.07-16.96-
Change in Working Capital
2.282.913.444.44-1.97
Source: S&P Capital IQ. Standard template. Financial Sources.